GÖTTINGEN, Germany --(BUSINESS WIRE)--
At today’s Annual Shareholders’ Meeting in Göttingen, Germany, shareholders granted discharge to the Executive Board and the Supervisory Board and approved the boards’ proposals by a large majority. They passed the resolution to pay dividends of 0.62 euros per preference share (previous year: 0.51 euros) and 0.61 euros per ordinary share (previous year: 0.50 euros). The total amount disbursed will rise accordingly by 21.8% year over year from 34.5 million euros to 42.1 million euros. Sartorius AG’s payout ratio is at the previous year’s level, 24.0%.
Presentation by Dr. Joachim Kreuzburg, Executive Board Chairman and CEO, as well as further information on the 2019 Annual General Shareholders’ Meeting
Current image files
April 18, 2019 Publication of first-quarter figures for 2019
July 19, 2019 Publication of first-half figures for 2019
October 22, 2019 Publication of nine-month figures for 2019
A profile of Sartorius
The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2018, the company earned sales revenue of some 1.57 billion euros. Currently, more than 8,100 people work at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
(c)Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.